Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06049433 · ClinicalTrials.gov registry record · NA

Maternal Mental Health Access - MaMa

A NA study of Postpartum Depression and Perinatal Depression, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06049433: Recruiting NA study of Postpartum Depression and Perinatal Depression, sponsored by University of Utah.

NCT06049433 is a NA study of Postpartum Depression and Perinatal Depression that is actively recruiting participants, run by University of Utah. The registered enrollment target is 120 participants, below the 473-participant average among 47 other Postpartum Depression trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06049433, a NA study of Postpartum Depression and Perinatal Depression, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This hybrid effectiveness-implementation project will allow the team to evaluate and refine implementation in preparation for future multisite trials to ultimately move the Evidence-Based Intervention (EBI) to scale among diverse populations. The plan is to enroll 120 at-risk pregnant and postpartum women from rural, urban, and Latino populations. Using a randomized preference design to also evaluate patient and sociocultural factors in participation and symptom trajectory. Using the Implementation Research Logic Model, the team will evaluate the implementation feasibility and acceptability of a remote-access and on-demand MBCT PD prevention intervention that is integrated within maternal clinical care settings using an existing patient portal. Successful achievement of the study aims will result in a refined implementation protocol for future studies that are sufficiently powered to evaluate the effectiveness of an integrated Digital Mental Health Technology and to estimate the cost/benefit ratio

Primary Outcome

EPDS Scores are between 0 and 30, with scores 13 and above indicating depressive illness, or a high risk of developing a depressive disorder. Using scores that are between 9-20 Qualitative; semi structured interview Quantitative; patient satisfaction survey, number of referrals for at-risk patients, patients registering on YoMingo. focus groups, individual interviews, questionnaires

Interventions

  • BEHAVIORAL Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention
  • BEHAVIORAL On-Demand + Discussion board (DB)
  • BEHAVIORAL Arm 2
  • BEHAVIORAL On Demand (OD) + Video Conference (VC)
  • BEHAVIORAL Arm 3

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-04-04
Est. Completion 2025-12-30
Phase NA
University of Utah

818 total trials

What NCT06049433 shows while recruiting

NCT06049433 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 47 other Postpartum Depression trials with a reported enrollment target (75% lower).

The record links to 2 conditions, with Postpartum Depression appearing as the primary indexed condition, and to 5 interventions - of which Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention is the first listed.

NCT06049433 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT06049433 about?

NCT06049433 is a clinical study titled "Maternal Mental Health Access - MaMa". This hybrid effectiveness-implementation project will allow the team to evaluate and refine implementation in preparation for future multisite trials to ultimately move the Evidence-Based Intervention (EBI) to scale among diverse populations. The plan is to enroll 120 at-risk pregnant and postpartum...

What is the current status of trial NCT06049433?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-04-04. Estimated completion is 2025-12-30.

What conditions does trial NCT06049433 study?

This clinical trial studies the following conditions: Postpartum Depression, Perinatal Depression.

What interventions are being tested in trial NCT06049433?

The interventions under investigation include: Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention (BEHAVIORAL), On-Demand + Discussion board (DB) (BEHAVIORAL), Arm 2 (BEHAVIORAL), On Demand (OD) + Video Conference (VC) (BEHAVIORAL), Arm 3 (BEHAVIORAL).

Who is sponsoring clinical trial NCT06049433?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06049433 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06049433's enrollment target sits among peer trials

120 22nd of 47 higher than 26 of 47 other Postpartum Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06049433, the US trial registry maintained by the National Library of Medicine. NCT06049433 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.